CVR — Chicago Rivet & Machine Co. — is trading at $11.80 after a sharp 10% week-on-week recovery, and the catalyst is clear: the company's full-year results, released April 21-22, showed a dramatically narrowed net loss of $1.08M against $5.6M in 2024 on $27.9M in net sales.
The bounce looks like relief rather than conviction. Earnings history shows CVR has closed lower after every one of the four most recent results events — the worst being a 28% five-day decline following March 24's print, and a further 13% one-day drop tied to the March 27 announcement. Even the "better" reactions involved a 1.4% day-one dip and a 4% five-day slide. The pattern is consistent: good news, bad tape. With no next earnings date confirmed yet, the stock is trading off the relief of improved financials without an immediate catalyst to test the pattern again.
Short interest tells a negligible story here. Estimated short positions have collapsed from 2,150 shares in late March to just 153 shares now — a 93% reduction over the past month. That's not a meaningful squeeze; it's an already-thin position evaporating on an illiquid micro-cap. Days to cover is 1.0. The borrow market is loose, with availability in no way constrained. Cost to borrow has edged up to 15.3% over the past week — a 11% increase — but that follows a steady decline from peaks near 22.6% in February. At current short levels, the CTB number is more of a market-making artefact than a signal.
Ownership is the more interesting angle. John Morrissey, a 10%+ shareholder, added 2,537 shares at $14.36 in December — the most recent insider activity, and notable only because it happened well above the current price of $11.80. The Morrissey family collectively controls close to 20% of shares outstanding, with the Estate of Walter Morrissey holding another 8.7%. Dimensional Fund Advisors holds 5.9% as of March 2026, steady and unchanged. Renaissance Technologies trimmed slightly — by 2,100 shares as of December — but remains a holder. The register is tightly held and illiquid; any meaningful institutional shift would move the stock.
There are no analyst ratings or price targets available for this name. That absence is itself informative — CVR is a micro-cap industrial with minimal sell-side coverage, and price discovery here happens through earnings releases and sporadic trading rather than Wall Street consensus. The stock's ORTEX short score of 33.8 is unremarkable, ranking near the mid-point of the universe, consistent with a name where shorts have almost entirely vacated and no new directional pressure has built.
What to watch next: the annual meeting and any further commentary on the trajectory of the net loss improvement — narrowing from $5.6M to $1.08M is a significant operational shift, and whether that continues into 2026 will drive the next re-rating attempt for this thinly traded name.
See the live data behind this article on ORTEX.
Open CVR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
